Dynavax Technologies Corp. is a clinical-stage biopharmaceutical company that uses toll-like receptor biology to discover and develop novel vaccines and therapeutics. The company's development programs are organized under its three areas of focus: vaccine adjuvants, cancer immunotherapy, and autoimmune and inflammatory diseases. Its lead product candidate is HEPLISAV, a Phase III investigational adult hepatitis B vaccine. The company's other products under pipeline are SD-101, DV1179 Autoimmune Disease and AZD1419 Asthma Therapy. Dynavax Technologies was founded by Lawrence M. Lichtenstein, Dennis A. Carson and Eyal Raz on August 29, 1996 and is headquartered in Berkeley, CA.
Market Cap | 1.54 Billion | Shares Outstanding | 124.922 Million | Avg 30-day Volume | 2.503 Million |
P/E Ratio | 0.0 | Dividend Yield | 0.0 | EPS | 0.04 |
Price to Revenue | 9.7032 | Debt to Equity | 3.0636 | EBITDA | -55.274 Million |
Price to Book Value | 7.6959 | Operating Margin | -146.8733 | Enterprise Value | 466.468 Million |
Current Ratio | 3.746 | EPS Growth | 0.639 | Quick Ratio | 2.425 |
1 Yr BETA | 1.5714 | 52-week High/Low | 21.39 / 7.26 | Profit Margin | -161.6292 |
Operating Cash Flow Growth | 23.918 | Altman Z-Score | -3.9629 | Free Cash Flow to Firm | -85.471 Million |
Earnings Report | 2022-08-04 |
Please sign in first
none
6 Thousand total shares from 1 transactions
6 Thousand total shares from 1 transactions
Insider Name | Type | Last Reported Shares Held | Last Reported Date | Filings in past year |
---|---|---|---|---|
|
27,857 | 2022-05-26 | 1 | |
|
27,857 | 2022-05-26 | 1 | |
|
27,857 | 2022-05-26 | 2 | |
|
20,893 | 2022-05-26 | 3 | |
|
27,857 | 2022-05-26 | 2 | |
|
27,857 | 2022-05-26 | 1 | |
|
27,857 | 2022-05-26 | 3 | |
|
13,929 | 2022-05-26 | 3 | |
|
27,857 | 2022-05-26 | 1 | |
|
27,857 | 2022-05-26 | 1 | |
BURGESS JUSTIN PRINCIPAL ACCOUNTING OFFICER |
|
13,708 | 2022-05-16 | 5 |
NOVACK DAVID F PRESIDENT & COO |
|
223,288 | 2022-03-02 | 8 |
JANSSEN ROBERT SENIOR VICE PRESIDENT |
|
93,450 | 2022-03-02 | 7 |
SPENCER RYAN CEO AND DIRECTOR |
|
743,084 | 2022-03-02 | 2 |
MACDONALD KELLY SVP AND CFO |
|
106,500 | 2022-02-10 | 1 |
OSTRACH MICHAEL S SENIOR VICE PRESIDENT |
|
0 | 2021-02-03 | 0 |
|
0 | 2020-05-28 | 0 | |
JOHNSON DAVID LOUIS VICE PRESIDENT |
|
48,380 | 2020-03-13 | 0 |
COFFMAN ROBERT SENIOR VICE PRESIDENT |
|
77,768 | 2019-06-02 | 0 |
GRAY EDDIE CEO AND DIRECTOR |
|
304,597 | 2019-06-02 | 0 |
|
0 | 2019-05-30 | 0 | |
|
0 | 2019-05-30 | 0 | |
|
0 | 2017-06-02 | 0 | |
|
0 | 2014-05-28 | 0 | |
|
0 | 2014-05-28 | 0 | |
TUCK STEPHEN F VP, GLOBAL TECHNICAL OPS |
|
0 | 2013-02-05 | 0 |
LEW JENNIFER VP, FINANCE & PAO |
|
0 | 2013-02-05 | 0 |
MARTIN J TYLER PRESIDENT, CMO & DIRECTOR |
|
222,089 | 2012-11-16 | 0 |
|
3,031,431 | 2012-10-16 | 0 | |
LARSON CHRISTINE R VP AND CHIEF FINANCIAL OFFICER |
|
0 | 2012-08-13 | 0 |
JANOWICZ ZBIGNIEW CEO DYNAVAX EUROPE |
|
0 | 2012-03-09 | 0 |
|
0 | 2010-05-12 | 0 | |
|
0 | 2010-05-12 | 0 | |
SYMPHONY CAPITAL GP, L.P. SYMPHONY GP, LLC SYMPHONY STRATEGIC PARTNERS LLC |
|
9,031,431 | 2010-04-16 | 0 |
|
17,115,404 | 2009-09-10 | 0 | |
|
25,254,628 | 2009-06-03 | 0 | |
SMELTZER DEBORAH A VP, OPERATIONS & CFO |
|
0 | 2009-03-10 | 0 |
DEERFIELD SPECIAL SITUATIONS FUND, L.P. DEERFIELD SPECIAL SITUATIONS FUND INTERNATIONAL LTD |
|
No longer subject to file | 2008-10-22 | 0 |
SANDERS MARTIN E EVP AND CDO |
|
0 | 2008-10-03 | 0 |
DEERFIELD SPECIAL SITUATIONS FUND, L.P. |
|
1,250,000 | 2007-07-18 | 0 |
|
0 | 2007-07-18 | 0 | |
|
0 | 2007-07-18 | 0 | |
HENN TIMOTHY G VP, FINANCE & ADMINISTRATION |
|
20,000 | 2007-02-02 | 0 |
VAN NEST GARY A VP, PRECLINICAL RESEARCH |
|
25,000 | 2007-02-02 | 0 |
|
10,030 | 2006-11-14 | 0 | |
|
4,851,538 | 2006-10-04 | 0 | |
|
10,000 | 2006-06-14 | 0 | |
|
328,447 | 2006-05-15 | 0 | |
LEVITT DANIEL J VICE PRESIDENT |
|
50,000 | 2006-02-14 | 0 |
Reporting Owners | Filing Date | Trans Date | Trans Code | Shares | Share Price | Acquired Disposed |
Shares Owned after | D/I | 10b5 | Perf 1d* | Perf 5d* | Perf 1m* | Max Gain | Max Gain Days | Max Loss | Max Loss Days |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-05-27 17:00:51 -0400 | 2022-05-26 | A | 5,357 | a | 5,357 | direct | ||||||||||
2022-05-27 17:00:55 -0400 | 2022-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2022-05-27 17:00:55 -0400 | 2022-05-26 | A | 5,357 | a | 5,357 | direct | ||||||||||
2022-05-27 17:29:43 -0400 | 2022-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2022-05-27 17:29:43 -0400 | 2022-05-26 | A | 5,357 | a | 5,357 | direct | ||||||||||
2022-05-27 17:01:59 -0400 | 2022-05-26 | A | 11,250 | a | 11,250 | direct | ||||||||||
2022-05-27 17:01:59 -0400 | 2022-05-26 | A | 2,679 | a | 2,679 | direct | ||||||||||
2022-05-27 17:01:01 -0400 | 2022-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2022-05-27 17:01:01 -0400 | 2022-05-26 | A | 5,357 | a | 5,357 | direct | ||||||||||
2022-05-27 17:01:06 -0400 | 2022-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2022-05-27 17:01:06 -0400 | 2022-05-26 | A | 5,357 | a | 5,357 | direct | ||||||||||
2022-05-27 17:00:51 -0400 | 2022-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2022-05-27 17:00:38 -0400 | 2022-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2022-05-27 17:00:38 -0400 | 2022-05-26 | A | 5,357 | a | 5,357 | direct | ||||||||||
2022-05-27 17:01:00 -0400 | 2022-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2022-05-27 17:01:00 -0400 | 2022-05-26 | A | 5,357 | a | 5,357 | direct | ||||||||||
2022-05-27 17:01:34 -0400 | 2022-05-26 | A | 22,500 | a | 22,500 | direct | ||||||||||
2022-05-27 17:01:34 -0400 | 2022-05-26 | A | 5,357 | a | 5,357 | direct | ||||||||||
2022-05-27 17:01:45 -0400 | 2022-05-26 | A | 16,875 | a | 16,875 | direct | ||||||||||
2022-05-27 17:01:45 -0400 | 2022-05-26 | A | 4,018 | a | 4,018 | direct | ||||||||||
2022-05-18 18:16:54 -0400 | 2022-05-17 | S | 6,000 | $10.00 | d | 3,854 | direct | -3.3989 | 4.4723 | 5.4562 | 5 | -3.3989 | 2 | |||
2022-05-18 18:16:54 -0400 | 2022-05-16 | M | 6,000 | a | 9,854 | direct | -3.3989 | 4.4723 | 5.4562 | 5 | -3.3989 | 2 | ||||
2022-05-18 18:16:54 -0400 | 2022-05-16 | M | 6,000 | d | 0 | direct |
* -
Code | Definition |
---|---|
A | Grant, award or other acquisition pursuant to Rule 16b-3(d) |
C | Conversion of derivative security |
D | Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 |
G | Bona fide gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities |
J | Other acquisition or disposition |
L | Small acquisition under Rule 16a-6 |
M | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 |
O | Exercise of out-of-the-money derivative security |
P | Open market or private purchase of non-derivative or derivative security |
S | Open market or private sale of non-derivative or derivative security |
U | Disposition pursuant to a tender of shares in a change of control transaction |
W | Acquisition or disposition by will or the laws of descent and distribution |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |
Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers
Security | Date/Time | Rebate Rate | Fee Rate | Shares Available |
---|
Holder | Issuer | Net Short Position | Position Date | Origin |
---|---|---|---|---|
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund | DVAX | -94175.0 shares, $-1154585.5 | 2022-02-28 | N-PORT |
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund | DVAX | -7739.0 shares, $-100374.83 | 2022-01-31 | N-PORT |
JNL Series Trust- JNL Multi-Manager Alternative Fund | DVAX | -150029.0 shares, $-1626314.36 | 2022-03-31 | N-PORT |
LAZARD FUNDS INC- Lazard Enhanced Opportunities Portfolio | DVAX | -97365.0 shares, $-1055436.6 | 2022-03-31 | N-PORT |